Glaukos GKOS recently announced positive data from a new 36-month follow-up analysis of its two Phase 3 pivotal clinical ...

Umoja Biopharma has announced the closing of an oversubscribed $100m Series C financing round to progress CAR-T cell therapy pipeline.

Commissioner Robert Califf, M.D., and other senior FDA officials recently published a “Special Communication” in JAMA describing FDA’s concerns with the use of AI in medical product development, ...

EDETEK Inc., a digital clinical platform company, announced the launch of R&D Cloud, a software ecosystem that addresses ...

Corporate: C4T further strengthened its leadership across its management team and Board of Directors to supports its evolution ... CFT1946 is designed to be potent and selective against the BRAF V600 ...

BridgeBio Pharma also said it expects $105 million in regulatory milestones from acoramidis - sold under the brand name Attruby - approvals in Europe and Japan in the first half of the year, and that ...

As of January 6, 2025, there were six evaluable patients in the Phase 2a arm evaluating IMM-1-104 with modified FOLFIRINOX in ...

There are over 300 glucagon-like peptide-1 receptor (GLP-1R) drugs in an active stage of development as the astounding success of Novo Nordisk’s GLP-1R obesity drug, Wegovy, has ignited a surge in ...

NDAQ:KNSA) Kiniksa Pharmaceuticals Reports Preliminary 2024 Net Product Revenue and Provides 2025 Net Product Revenue Guidance ...

“Looking ahead, we are excited about Cybin’s next phase of investigation and growth and for the upcoming milestones, including a readout of topline efficacy data from our CYB004 Phase 2 GAD study in ...

Biotechnology is suitable for those interested in biology, research, and laboratory while Information Technology is ideal for ...